Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shin

Showing results (901-910 of 957) with videos related to

Pageof 96
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2013
Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studiesDong M Shin, Hongzheng Zhang, Nabil F Saba, et al.
Cancer Research|April 7, 2017
Modulation of Bax and mTOR for Cancer TherapeuticsRui Li, Chunyong Ding, Jun Zhang, et al.
JAMA Dermatology|August 25, 2021
Patient Quality of Life After Interpolated Flap Repair of Nasal Mohs Surgery Defects: A Multicenter Prospective Cohort StudyTess M Lukowiak, Allison M Perz, Surya A Veerabagu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaChristine H Chung, Jiannong Li, Conor E Steuer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 3, 2013
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic studyNabil F Saba, Selwyn J Hurwitz, Scott A Kono, et al.
JACC. Advances|September 6, 2024
Anxiety and Depression Associated With Increased Cardiovascular Disease Risk Through Accelerated Development of Risk FactorsGiovanni Civieri, Shady Abohashem, Simran S Grewal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2024
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker AnalysisNabil F Saba, Ritu Chaudhary, Kedar Kirtane, et al.
Journal of the American College of Cardiology|April 17, 2024
Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical ActivityHadil Zureigat, Michael T Osborne, Shady Abohashem, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
PIVOT: an open-source tool for multi-omic spatial data registrationAndré Forjaz, Valentina Matos Romero, Ian Reucroft, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal CancerNabil F Saba, Seth Force, Charley Staley, et al.
Pageof 96

Showing results (901-910 of 957) with videos related to

Sort By:
Pageof 96
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2013
Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studiesDong M Shin, Hongzheng Zhang, Nabil F Saba, et al.
Cancer Research|April 7, 2017
Modulation of Bax and mTOR for Cancer TherapeuticsRui Li, Chunyong Ding, Jun Zhang, et al.
JAMA Dermatology|August 25, 2021
Patient Quality of Life After Interpolated Flap Repair of Nasal Mohs Surgery Defects: A Multicenter Prospective Cohort StudyTess M Lukowiak, Allison M Perz, Surya A Veerabagu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaChristine H Chung, Jiannong Li, Conor E Steuer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 3, 2013
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic studyNabil F Saba, Selwyn J Hurwitz, Scott A Kono, et al.
JACC. Advances|September 6, 2024
Anxiety and Depression Associated With Increased Cardiovascular Disease Risk Through Accelerated Development of Risk FactorsGiovanni Civieri, Shady Abohashem, Simran S Grewal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2024
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker AnalysisNabil F Saba, Ritu Chaudhary, Kedar Kirtane, et al.
Journal of the American College of Cardiology|April 17, 2024
Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical ActivityHadil Zureigat, Michael T Osborne, Shady Abohashem, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
PIVOT: an open-source tool for multi-omic spatial data registrationAndré Forjaz, Valentina Matos Romero, Ian Reucroft, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal CancerNabil F Saba, Seth Force, Charley Staley, et al.
Pageof 96